Does VUTRISIRAN Cause Product dose omission issue? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Product dose omission issue have been filed in association with VUTRISIRAN (AMVUTTRA). This represents 3.2% of all adverse event reports for VUTRISIRAN.
45
Reports of Product dose omission issue with VUTRISIRAN
3.2%
of all VUTRISIRAN reports
11
Deaths
25
Hospitalizations
How Dangerous Is Product dose omission issue From VUTRISIRAN?
Of the 45 reports, 11 (24.4%) resulted in death, 25 (55.6%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VUTRISIRAN. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does VUTRISIRAN Cause?
Death (244)
Hospitalisation (143)
Intentional dose omission (80)
Therapy interrupted (66)
Fall (65)
Fatigue (56)
Pain in extremity (43)
Dyspnoea (42)
Gait disturbance (42)
Asthenia (37)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which VUTRISIRAN Alternatives Have Lower Product dose omission issue Risk?
VUTRISIRAN vs VX-950
VUTRISIRAN vs VYVANSE
VUTRISIRAN vs WARFARIN
VUTRISIRAN vs WATER
VUTRISIRAN vs WELLBUTRIN